5640.0000 -22.00 (-0.39%)
NSE Dec 22, 2025 15:31 PM
Volume: 3,172
 

5640.00
-0.39%
IDBI Capital
Given the change in the product mix, we have maintained our CY18 revenue As we roll one-year forward our valuation to CY19E, taking in account that major products coming out of the purview NLEM and continuous launches in the Indian...
Number of FII/FPI investors increased from 149 to 160 in Sep 2025 qtr.
More from Procter & Gamble Health Ltd.
Recommended